abrdn Life Sciences Investors Total Liabilities

As of the most recent data (March 2026), HQL shows a total liabilities of $2.4M. That compares with $15M in the prior-year period — down 84.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, HQL's total liabilities is now $2.4M (was $15M) — a 84.4% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether abrdn Life Sciences Investors is outperforming or lagging.

Tracking HQL's total liabilities over time shows whether abrdn Life Sciences Investors is scaling, shrinking, or reshaping that part of the business. The current reading is $2.4M That compares with $15M in the prior-year period — down 84.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has abrdn Life Sciences Investors's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $2.4M) with ownership activity and broader fundamentals.